TREM1 and neoplasm: Tumor-infiltrating MDSCs harvested from TREM1-deficient mice exhibited diminished suppressive capacity on the proliferation of CD3+ T cells activated with anti-CD3/anti-CD28 compared with their TREM1-positive counterparts (Figure 4D).